Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126861821 | 12686182 | 1 | I | 20160102 | 20160104 | 20160825 | 20160825 | PER | US-PERRIGO-16US000071 | PERRIGO | 49.97 | YR | F | Y | 118.37000 | KG | 20160825 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126861821 | 12686182 | 1 | PS | NICOTINE POLACRILEX | NICOTINE | 1 | Buccal | 4 MG, SINGLE | Y | 4ME1166 | 90711 | 4 | MG | LOZENGE | |||||
126861821 | 12686182 | 2 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 40 MG | U | UNKNOWN | 0 | ||||||||
126861821 | 12686182 | 3 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25 MG | U | UNKNOWN | 0 | ||||||||
126861821 | 12686182 | 4 | C | FISH OIL | FISH OIL | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
126861821 | 12686182 | 5 | C | NIACIN. | NIACIN | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
126861821 | 12686182 | 6 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
126861821 | 12686182 | 7 | C | MULTIVITAMINS, PLAIN | VITAMINS | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
126861821 | 12686182 | 8 | C | GLUCOSAMINE MSM | 2 | Unknown | UNK | U | UNKNOWN | 0 | |||||||||
126861821 | 12686182 | 9 | C | ACIDOPHILUS PROBIOTIC | 2 | Unknown | UNK | U | UNKNOWN | 0 | |||||||||
126861821 | 12686182 | 10 | C | LORATADINE. | LORATADINE | 1 | Unknown | 10 MG | U | UNKNOWN | 0 | ||||||||
126861821 | 12686182 | 11 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | UNK | U | UNKNOWN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126861821 | 12686182 | 1 | Smoking cessation therapy |
126861821 | 12686182 | 2 | Gastrooesophageal reflux disease |
126861821 | 12686182 | 3 | Oedema |
126861821 | 12686182 | 4 | Supplementation therapy |
126861821 | 12686182 | 5 | Supplementation therapy |
126861821 | 12686182 | 6 | Supplementation therapy |
126861821 | 12686182 | 7 | Supplementation therapy |
126861821 | 12686182 | 8 | Arthritis |
126861821 | 12686182 | 9 | Supplementation therapy |
126861821 | 12686182 | 10 | Supplementation therapy |
126861821 | 12686182 | 11 | Supplementation therapy |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126861821 | 12686182 | Oral discomfort | |
126861821 | 12686182 | Salivary hypersecretion | |
126861821 | 12686182 | Throat tightness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126861821 | 12686182 | 1 | 20160102 | 20160102 | 0 |